The first prospective, randomized biomarker validation trial in patients with muscle-invasive bladder cancer treated with chemotherapy provides valuable insights into the clinical utility of biomarkers for prognostication and treatment response prediction, informing personalized management strategies for this aggressive malignancy.
September 2022
Weight loss may reduce the risk of developing colorectal adenoma, offering potential preventive strategies to mitigate the risk of colorectal cancer precursor lesions and promote colorectal health in at-risk individuals.
August 2022
A new study calls for novel strategies targeting the dynamic landscape of heterogeneous tumors in primary liver cancer, emphasizing the importance of personalized treatment approaches for improving patient outcomes.
August 2022
Postoperative outcomes among patients undergoing adrenalectomy for malignant pheochromocytoma, stratified by surgical approach, provide insights into optimal surgical management and perioperative care strategies in this rare neuroendocrine tumor.
June 2022
Implementation of electronic symptom monitoring after oncology surgery reduces patient anxiety and nursing workload, enhancing postoperative care and patient satisfaction in oncology settings.
May 2022
One in four new breast cancers and one in five colon cancers in Canada are attributed to alcohol consumption, underscoring the need for public health interventions to address alcohol-related cancer risk factors and promote healthy lifestyle behaviors.
April 2022
Practice patterns in the surgical management of small neuroendocrine tumors of the pancreas are examined, with a focus on comparing postoperative outcomes between resection and enucleation procedures to inform treatment decision-making and optimize patient care.
March 2022